Blogs
Medical Devices-USA/Europe Regulatory…
USA (FDA)
Medical Device User Fee Rates for Fiscal Year 2024
The FD&C Act, as amended by MD…
Pharma/Biotech – USA, Europe Re…
US
FY 2024 Biosimilar User Fees Show Sharp Decrease, Other Fees Increase
While prescription dru…
Pharma/Biotech – Asia, ROW Regu…
ASIA
Singapore
Guidance on therapeutic product registration in Singapore
This guidance docum…
Medical Devices-Asia and ROW Regulato…
ASIA
SINGAPORE (HSA)
HSA’s SRA status for In-vitro Diagnostic Medical Devices (IVD)
An SRA i…
Regulatory Intelligence shows path to…
Pharma companies need to be well-versed regarding regulatory intelligence while develop, manufacture …
Pharma/Biotech – USA, Europe Re…
USA
No Big-Picture Impact for Manufacturers in CMS IRA Updates
In the face of multiple lawsuits…
Categories
- Biopharma (52)
- Consumer Health (14)
- Cosmetics (8)
- Diagnostics (6)
- Digital Health (6)
- Food (1)
- Medical Device (97)
- OTC (3)
- Regulatory Intelligence (4)
- Standards (34)
Most used Tags
Asia Regulatory News (18)
BioTech (10)
Biotech Regulatory News (10)
Compliance (7)
Compliance Management (5)
Consumer Health (7)
cosmetics (4)
EU Regulatory News (10)
Europe Regulatory News (12)
FDA (9)
FDA Updates (5)
Global Compliance (7)
Global Health (5)
Healthcare Industry (6)
Medical Device (4)
medical device labeling requirements (5)
Medical Devices (38)
MHRA (6)
Pharma (11)
Pharma Regulatory News (10)
Regulatory Affairs (6)
Regulatory Changes (4)
Regulatory Compliance (7)
Regulatory Intelligence (12)
Regulatory News (36)
Regulatory Updates (32)
ROW Regulatory News (15)
Swissmedic (5)
USA Regulatory News (21)
US FDA (8)